Texas Medicaid Restricts Zyprexa Use; Effect To Stabilize Soon, Lilly Says
Executive Summary
The impact of Texas Medicaid's decision to require prior authorization for Zyprexa will stabilize after about six months, Lilly Investor Relations Manager Heidi Straub said April 19
You may also be interested in...
Lilly Elevates Santini To Senior VP; “Access & Policy” Are Priorities
Lilly is placing additional emphasis on prescription drug access and pricing issues with the appointment of U.S. Operations President Gino Santini to senior VP-corporate strategy and policy
Lilly Elevates Santini To Senior VP; “Access & Policy” Are Priorities
Lilly is placing additional emphasis on prescription drug access and pricing issues with the appointment of U.S. Operations President Gino Santini to senior VP-corporate strategy and policy
Lilly Zyprexa Marketing Going “Back to Basics” With Focus On Efficacy
Lilly is taking a "back to basics" approach on marketing for its atypical antipsychotic Zyprexa to grow U.S. market share